Unknown

Dataset Information

0

CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.


ABSTRACT:

Objective

To assess the prognostic and clinicopathological characteristics of CD147 in human bladder cancer.

Methods

Studies on CD147 expression in bladder cancer were retrieved from PubMed, EMBASE, the Cochrane Library, Web of Science, China National Knowledge Infrastructure, and the WanFang databases. Outcomes were pooled with meta-analyzing softwares RevMan 5.3 and STATA 14.0.

Results

Twenty-four studies with 25 datasets demonstrated that CD147 expression was higher in bladder cancer than in non-cancer tissues (OR=43.64, P<0.00001). Moreover, this increase was associated with more advanced clinical stages (OR=73.89, P<0.0001), deeper invasion (OR=3.22, P<0.00001), lower histological differentiation (OR=4.54, P=0.0005), poorer overall survival (univariate analysis, HR=2.63, P<0.00001; multivariate analysis, HR=1.86, P=0.00036), disease specific survival (univariate analysis, HR=1.65, P=0.002), disease recurrence-free survival (univariate analysis, HR=2.78, P=0.001; multivariate analysis, HR=5.51, P=0.017), rate of recurrence (OR=1.91, P=0.0006), invasive depth (pT2?T4 vs. pTa?T1; OR=3.22, P<0.00001), and histological differentiation (low versus moderate-to-high; OR=4.54, P=0.0005). No difference was found among disease specific survival in multivariate analysis (P=0.067), lymph node metastasis (P=0.12), and sex (P=0.15).

Conclusion

CD147 could be a biomarker for early diagnosis, treatment, and prognosis of bladder cancer.

SUBMITTER: Li H 

PROVIDER: S-EPMC5617530 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.

Li Hongru H   Xu Yadong Y   Li Hui H  

Oncotarget 20170715 37


<h4>Objective</h4>To assess the prognostic and clinicopathological characteristics of CD147 in human bladder cancer.<h4>Methods</h4>Studies on CD147 expression in bladder cancer were retrieved from PubMed, EMBASE, the Cochrane Library, Web of Science, China National Knowledge Infrastructure, and the WanFang databases. Outcomes were pooled with meta-analyzing softwares RevMan 5.3 and STATA 14.0.<h4>Results</h4>Twenty-four studies with 25 datasets demonstrated that CD147 expression was higher in b  ...[more]

Similar Datasets

| S-EPMC6190559 | biostudies-literature
| S-EPMC8440888 | biostudies-literature
| S-EPMC5016850 | biostudies-other
| S-EPMC5366185 | biostudies-literature
| S-EPMC8445105 | biostudies-literature
| S-EPMC5289528 | biostudies-literature
| S-EPMC9913674 | biostudies-literature
| S-EPMC2914705 | biostudies-literature
| S-EPMC9189346 | biostudies-literature
| S-EPMC5655276 | biostudies-literature